DR Reddys director files initial ownership report

DR REDDYS LABORATORIES LTD director Kodumudi Pranatharthi Haran Krishnan has filed a Form 3, which is an initial statement of beneficial ownership for company insiders.

Accepted by SEC EDGAR 03/27/2026 - 08:38 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director Kodumudi Pranatharthi Haran Krishnan has filed a Form 3, which is an initial statement of beneficial ownership for company insiders. This filing establishes his official status as a director and sets the baseline record of his holdings for future Form 4 or Form 5 updates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RDY Form 3 filing for Kodumudi Pranatharthi Haran Krishnan mean?

The Form 3 for RDY records Kodumudi Pranatharthi Haran Krishnan’s initial beneficial ownership as a director. It creates a baseline of his insider position so that any future changes must be reported on Forms 4 or 5, improving transparency for investors.

Who is the insider reporting on Form 3 for DR REDDYS LABORATORIES LTD (RDY)?

The reporting person on this Form 3 is Kodumudi Pranatharthi Haran Krishnan, identified as a director of DR REDDYS LABORATORIES LTD. The filing confirms his role as a company insider, triggering ongoing SEC reporting obligations for changes in his beneficial ownership.

Does the RDY Form 3 show any insider buy or sell transactions?

No transactions are reported in this RDY Form 3. Form 3 is an initial ownership statement, and the provided data show zero buy, sell, acquire, or dispose transactions, meaning it only establishes baseline beneficial ownership without recording trading activity.

Why is Form 3 important for DR REDDYS LABORATORIES LTD investors?

Form 3 is important because it formally identifies insiders like directors and records their starting ownership. For RDY, this filing means future changes in this director’s holdings must be disclosed on subsequent forms, supporting better oversight of insider activity and potential alignment with shareholders.

Does the RDY Form 3 include any derivative securities information?

The RDY Form 3 data provided show no derivative securities in the derivativeSummary section. That means no options, warrants, or similar derivative positions are listed for this director in this initial ownership statement, based on the available excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

KODUMUDI PRANATHARTHI HARAN KRISHNAN

(Last) (First) (Middle)

L-3, GROUND FLOOR

HAUZ KHAS ENCLAVE

(Street)

NEW DELHI NEW DELHI 110016

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ KRISHNAN KODUMUDI PRANATHARTHIHARAN	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)